Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 4 for:    psilocybin, usona | Depression
Previous Study | Return to List | Next Study

A Study of Psilocybin for Major Depressive Disorder (MDD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03866174
Recruitment Status : Recruiting
First Posted : March 7, 2019
Last Update Posted : January 7, 2021
Sponsor:
Collaborators:
Signant Health
The Emmes Company, LLC
Information provided by (Responsible Party):
Usona Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2021
Estimated Study Completion Date : February 2021
Publications: